Business
- Sanofi expands SK bioscience deal for pneumococcal conjugate vaccines
23 Dec, 2024 - Vaccine Adjuvants Market Is Booming Worldwide | Pfizer, Valneva, Viropro
23 Dec, 2024 - Countries grapple with global shortage of oral cholera vaccine
23 Dec, 2024 - Vaccine Market : An Overview
23 Dec, 2024 - Insulin and Hepatitis B Vaccine Prices to go Down Soon
22 Dec, 2024 - Zydus Cadila in Association with Japan’s Takeda Pharma to Develop Chikungunya Vaccine
22 Dec, 2024 - Seum Institute, Valneva ink pact for single-shot chikungunya vaccine
22 Dec, 2024 - USA Delivers 11,200 Mpox Vaccines to Nigeria
21 Dec, 2024 - Vaxcyte a new buy at Goldman Sachs on vaccine platform, pneumonia asset (PCVX:NASDAQ)
20 Dec, 2024 - Global Partners invest US$45 million to boost African vaccine production
20 Dec, 2024 - Key Chickenpox Vaccine Market Trend 2024-2033: Innovative Drug Developments
20 Dec, 2024 - IO Biotech secures €57.5 million EIB loan for cancer vaccines
20 Dec, 2024 - Is Moderna Stock a Buy?
20 Dec, 2024 - Building vaccine and therapeutics manufacturing capacity in Asia Pacific
20 Dec, 2024 - Dx&Vx partners with Stanford to develop Covid-19 vaccine
20 Dec, 2024 - Global vaccine market report 2024
19 Dec, 2024 - Novavax adjusts vaccine deal with Australian government
19 Dec, 2024 - Merck’s RSV antibody could soon paddle into the rough waters of a crowded market
19 Dec, 2024 - Morningstar says CSL, Cochlear won’t be impacted by vaccine sceptic RFK Jr’s role
19 Dec, 2024 - Meningococcal Vaccine Market is Set to Grow from USD
19 Dec, 2024 - Abera and Orexo partner for vaccine powder formulations
18 Dec, 2024 - African Union gains $45M package to boost vaccine manufacturing in Senegal
18 Dec, 2024 - Zelluna Comes To Rescue Of Ultimovacs As Cancer Vaccine Is Jettisoned
18 Dec, 2024 - Arcturus shares maintain buy rating as EMA nods to COVID-19 vaccine
17 Dec, 2024 - BioVaxys Secures GMP-Grade Lipid Supply for Production of DPX-Based Vaccines in Advance of Preclinical and Clinical Program Ramp-Up
17 Dec, 2024 - Orexo Partners with Abera Bioscience to Revolutionize Nasal Vaccine Delivery with AmorphOX Technology
17 Dec, 2024 - Oral Vaccine Market Size to Hit USD 9.62 Billion by 2034
17 Dec, 2024 - Pfizer does not expect major vaccine policy changes under Trump in 2025
17 Dec, 2024 - Bavarian Nordic signs deal for MVA-BN mpox vaccine with Serum Institute
16 Dec, 2024 - Vaccine Adjuvants Market to Hit USD 0.96 Billion by 2029 with 6.5% CAGR | MarketsandMarkets™
16 Dec, 2024
0 Comments